E-LIB Suche - Ergebnisse für: Kiertiburanakul, Sasisopin

1

SARS-CoV-2-Specific Antibodies, B Cell and T Cell Immune Re..:

Phornkittikorn, Pattaraphorn ; Kantachuvesiri, Surasak ; Sobhonslidsuk, Abhasnee...
Vaccines. 12 (2024) 5 - p. 541 , 2024

Link: https://doi.org/10.3390/..

2

Incidence and Predicting Factors of Opportunistic Infection..:

Wongkittipong, Prapon ; Kiertiburanakul, Sasisopin
Journal of the International Association of Providers of AIDS Care (JIAPAC). 23 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

3

Optimal initial insulin dosage for managing steroid-induced..:

Ketaroonrut, Nuttavadee ; Kiertiburanakul, Sasisopin ; Sriphrapradang, Chutintorn
SAGE Open Medicine. 12 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

4

THU328 Appropriate Initial Insulin Dosage For Management Of..:

Ketaroonrut, Nuttavadee ; Kiertiburanakul, Sasisopin ; Sriphrapradang, Chutintorn
Journal of the Endocrine Society. 7 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1210/..

5

Cost-effectiveness analysis of HLA-B*13:01 screening for th..:

Kategeaw, Warittakorn ; Nakkam, Nontaya ; Kiertiburanakul, Sasisopin...
Journal of Medical Economics. 26 (2023) 1 - p. 1330-1341 , 2023

Link: https://doi.org/10.1080/..

6

Effects of pitavastatin on atherosclerotic-associated infla..:

Srichatrapimuk, Sirawat ; Wongsa, Artit ; Sungkanuparph, Somnuek...
AIDS Research and Therapy. 20 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Trends in hepatitis C virus coinfection and its cascade of ..:

Ross, Jeremy ; Rupasinghe, Dhanushi ; Avihingsanon, Anchalee...
PLOS ONE. 18 (2023) 6 - p. e0287909 , 2023

Link: https://doi.org/10.1371/..

8

494. Real-world effectiveness of tixagevimab/cilgavimab for..:

Rojanakit, Gun ; Kiertiburanakul, Sasisopin ; Boongird, Sarinya...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

9

1579. Incidence and Predicting Factors of Opportunistic Inf..:

Wongkittipong, Prapon ; Kiertiburanakul, Sasisopin
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

10

Bictegravir, emtricitabine, and tenofovir alafenamide versu..:

Avihingsanon, Anchalee ; Lu, Hongzhou ; Leong, Chee Loon...
The Lancet HIV. 10 (2023) 10 - p. e640-e652 , 2023

Link: https://doi.org/10.1016/..

11

Treatment Outcomes After Switching to Second-Line Anti-Retr..:

Sudsila, Pupe ; Teeraananchai, Sirinya ; Kiertiburanakul, Sasisopin...
Journal of the International Association of Providers of AIDS Care (JIAPAC). 22 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

12

330 WEEK 48 RESULTS OF A PHASE 3 RANDOMIZED CONTROLLED TRIA..:

Avihingsanon, Anchalee ; Lu, Hongzhou ; Leong, Chee Loon...
Gastroenterology. 164 (2023) 6 - p. S-1241 , 2023

Link: https://doi.org/10.1016/..

13

Efficacy and safety of switching to bictegravir, emtricitab..:

Avihingsanon, Anchalee ; Chetchotisakd, Ploenchan ; Kiertiburanakul, Sasisopin...
HIV Medicine. 24 (2022) 3 - p. 290-300 , 2022

Link: https://doi.org/10.1111/..

14

The Association of HLA-B*35 and GSTT1 Genotypes and Hepatot..:

Chanhom, Noppadol ; Jittikoon, Jiraphun ; Wattanapokayakit, Sukanya...
Journal of Personalized Medicine. 12 (2022) 6 - p. 940 , 2022

Link: https://doi.org/10.3390/..

15

Patterns and prognosis of holding regimens for people livin..:

Kim, Jung Ho ; Jiamsakul, Awachana ; Kiertiburanakul, Sasisopin...
PLOS ONE. 17 (2022) 3 - p. e0264157 , 2022

Link: https://doi.org/10.1371/..